Bone Biologics was founded to pursue regenerative medicine for bone. Bone Biologics is currently focusing its development efforts of its bone graft substitute product on bone regeneration in spinal fusion. Our proprietary platform technology, NELL , is a recombinant human protein growth factor that is essential for normal bone development.
Quote | Bone Biologics Corp (OTCMKTS:BBLG)
Last: | $7.5001 |
---|---|
Change Percent: | 0.0% |
Open: | $7.5001 |
Close: | $7.5001 |
High: | $7.5001 |
Low: | $7.5001 |
Volume: | 150 |
Last Trade Date Time: | 03/19/2021 04:42:06 am |
News | Bone Biologics Corp (OTCMKTS:BBLG)
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its com...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of an aggregate of 781,251 shares of its common stock (or common sto...
Message Board Posts | Bone Biologics Corp (OTCMKTS:BBLG)
Subject | By | Source | When |
---|---|---|---|
Only a few trades a year look this | 81vette | investorshub | 04/04/2023 3:26:53 PM |
9X relative vol,buckle up on this babe | 81vette | investorshub | 04/04/2023 2:29:23 PM |
$BBLG: Trying to bounce higher at 0.24 | makinezmoney | investorshub | 12/27/2022 4:24:50 PM |
How is Wallacebeth Capitals track record on its IPOs? | IPO$ | investorshub | 12/15/2022 5:34:11 PM |
Revenues chit the bed ! <> $0.00 | crudeoil24 | investorshub | 11/16/2022 1:05:37 PM |
News, Short Squeeze, Breakout and More Instantly...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its com...
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioV...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of an aggregate of 781,251 shares of its common stock (or common sto...